ADMP
Adamis Pharmaceuticals Corp
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
-100.0%
1 Year Change
-100.0%
Company Overview
Exchange
Next Earnings Date
Adamis Pharmaceuticals Corporation is a biopharmaceutical company focused on developing and commercializing specialty pharmaceutical products in various therapeutic areas. The company has historically focused on developing products for the treatment of allergies, respiratory diseases, and opioid overdose.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $9062.0 | $3.3m | - | $29465.0 | 0.00% | 0.89% |
| June 30, 2023 | $6945.0 | $11.36m | - | $46312.0 | 0.00% | 0.41% |
| March 31, 2023 | $1.45m | $7.88m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Adamis Pharmaceuticals Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.